B
Bullisch
Bullisch · 25%TDAC
$9.29
Szenariopreis
$10.910
+0.050 (+0.46%)Zum Schluss
Loading chart…
- Hoch
- 10.910
- Eröffnung
- 10.910
- Volumengewichteter Durchschnittskurs
- 10.91
- Volumen
- 315.00
- Marktkap.
- —
- Tief
- 10.910
- Umsatz
- 3.44K
- EV/EBITDA, TTM
- 0.00
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
KI-Analyse of Translational Development Acquisition Corp (TDAC)
KaufenTDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
Bewertungskennzahlen
Das aktuelle erwartete KGV von Translational Development Acquisition Corp (TDAC) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.
Alphio-AI-Kursszenarien für TDAC
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Event-Zeitleiste
News
5.010-30NewsfilterProLogium Appoints New Independent Director
- 8.510-12Newsfilter
ProLogium Advances Collaboration with Rimac on EV Battery Development
- 8.509-09Newsfilter
ProLogium Deepens Strategic Partnership with Kyushu Electric Power
- 8.508-24Newsfilter
ProLogium Appoints Rimac CEO to Board Amid Growth Phase
- 8.507-28Newsfilter
ProLogium Secures $50 Million Investment for Growth
TDAC FAQ – beantwortet von Alphio AI
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
TDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenÄhnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.